Skip to content

Complete Atrial Fibrillation Evaluation and Support (CArES): community-based atrial fibrillation health management and innovation practice project

Complete Atrial Fibrillation Evaluation and Support (CArES): community-based atrial fibrillation health management and innovation practice project

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097047
Enrollment
Unknown
Registered
2025-02-11
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Intervention Group (Topic 2):Implement digital health behaviour interventions (e.g. text message reminders) to promote personalised health education and management of anticoagulation therapy to patien
Control Group (Topic 2):Follow the existing conventional management model.
Standardized anticoagulation therapy group (Topic 1):None
Anticoagulation insufficiency group (Topic 1):None

Sponsors

Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Elderly people aged 65 and above who received physical examination in Guangzhou. 2. Atrial fibrillation (including paroxysmal, persistent or permanent atrial fibrillation) diagnosed by specialists through electrocardiogram (ECG) or electrocardiographic monitoring. 3.Atrial fibrillation should have been diagnosed within 12 months prior to enrolment or the patient should have a well-documented history of atrial fibrillation. 4.Participants should voluntarily enroll in the study, sign a written informed consent, and be willing to accept long-term follow-up and related data collection.

Exclusion criteria

Exclusion criteria: 1. Individuals < 65 years of age who do not meet the criteria for the Geriatric Physical Examination Programme. 2. Individuals who do not have a clear diagnosis of atrial fibrillation and only have isolated atrial flutter. 3.Individuals with a serious medical condition (e.g., end-stage cancer, severe heart failure, severe mental illness) that precludes cooperation with study follow-up or with an expected survival of less than 1 year. 4.Patients who reside out of state or have frequent relocation plans and are not expected to complete the full follow-up cycle. 5. Patients currently enrolled in an interventional clinical trial to avoid inter-study interference.

Design outcomes

Primary

MeasureTime frame
Incidence of cardiovascular events and their treatment;Adherence to anticoagulation therapy;

Secondary

MeasureTime frame
Lifestyle assessment;Physical and ancillary examination;

Countries

China

Contacts

Public ContactLin Xu

Sun Yat-sen University

xulin27@mail.sysu.edu.cn+86 20 8733 5523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026